HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study.

AbstractBACKGROUND:
This study was undertaken to evaluate the clinical characteristics and outcomes of patients with cancer requiring nonpalliative ventilatory support.
METHODS:
This was a secondary analysis of a prospective cohort study conducted in 28 Brazilian ICUs evaluating adult patients with cancer requiring invasive mechanical ventilation (MV) or noninvasive ventilation (NIV) during the first 48 h of their ICU stay. We used logistic regression to identify the variables associated with hospital mortality.
RESULTS:
Of 717 patients, 263 (37%) (solid tumors = 227; hematologic malignancies = 36) received ventilatory support. NIV was initially used in 85 patients (32%), and 178 (68%) received MV. Additionally, NIV followed by MV occurred in 45 patients (53%). Hospital mortality rates were 67% in all patients, 40% in patients receiving NIV only, 69% when NIV was followed by MV, and 73% in patients receiving MV only (P < .001). Adjusting for the type of admission, newly diagnosed malignancy (OR, 3.59; 95% CI, 1.28-10.10), recurrent or progressive malignancy (OR, 3.67; 95% CI, 1.25-10.81), tumoral airway involvement (OR, 4.04; 95% CI, 1.30-12.56), performance status (PS) 2 to 4 (OR, 2.39; 95% CI, 1.24-4.59), NIV followed by MV (OR, 3.00; 95% CI, 1.09-8.18), MV as initial ventilatory strategy (OR, 3.53; 95% CI, 1.45-8.60), and Sequential Organ Failure Assessment score (each point except the respiratory domain) (OR, 1.15; 95% CI, 1.03-1.29) were associated with hospital mortality. Hospital survival in patients with good PS and nonprogressive malignancy and without tumoral airway involvement was 53%. Conversely, patients with poor functional capacity and cancer progression had unfavorable outcomes.
CONCLUSIONS:
Patients with cancer with good PS and nonprogressive disease requiring ventilatory support should receive full intensive care, because one-half of these patients survive. On the other hand, provision of palliative care should be considered the main goal for patients with poor PS and progressive underlying malignancy.
AuthorsLuciano C P Azevedo, Pedro Caruso, Ulysses V A Silva, André P Torelly, Eliézer Silva, Ederlon Rezende, José J Netto, Claudio Piras, Suzana M A Lobo, Marcos F Knibel, José M Teles, Ricardo A Lima, Bruno S Ferreira, Gilberto Friedman, Alvaro Rea-Neto, Felipe Dal-Pizzol, Fernando A Bozza, Jorge I F Salluh, Márcio Soares, Brazilian Research in Intensive Care Network (BRICNet)
JournalChest (Chest) Vol. 146 Issue 2 Pg. 257-266 (Aug 2014) ISSN: 1931-3543 [Electronic] United States
PMID24480886 (Publication Type: Journal Article, Multicenter Study, Observational Study)
Topics
  • Adult
  • Brazil (epidemiology)
  • Female
  • Follow-Up Studies
  • Hospital Mortality (trends)
  • Humans
  • Inpatients
  • Intensive Care Units
  • Length of Stay (trends)
  • Male
  • Middle Aged
  • Neoplasms (mortality, therapy)
  • Noninvasive Ventilation (methods)
  • Palliative Care (methods)
  • Prognosis
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: